Physician profile
Natalie Brown
NPI 1609315324
$4,575.40
in general payments reported to CMS, 2019-2025
41 companies · $957 in 2025
The $957 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $712 · 2022: $1,361 · 2023: $653 · 2024: $893 · 2025: $957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,487 · Entertainment: $15.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.40 |
| Entertainment | $15.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $648.44 | 2021-2023 | |
| Pfizer INC. | $536.32 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $494.86 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $308.03 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $303.69 | 2022-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $296.65 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Abbott Laboratories | $289.48 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Octrode |
| Lucid Diagnostics INC. | $222.88 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $180.40 | 2021-2025 | Capvaxive, Gardasil 9, M-M-R II |
| Inspire Medical Systems, INC. | $167.65 | 2024-2025 | Inspire |
| Exact Sciences Corporation | $153.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $80.30 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $76.63 | 2021 | |
| Astellas Pharma US INC | $74.03 | 2023-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.83 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.